what are key considerations when launching a rare disease drug in a specialty-naive market?
Published 6 years ago • 145 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:44
what challenges exist with launching a specialty drug?
-
1:15
how does launching a personalized drug differ from other specialty drugs?
-
6:00
the latest trends and potential implications in rare disease, orphan drug management
-
2:00
rare disease drugs and market implications
-
1:31
challenges of launching rare disease therapies
-
1:25:07
one in a million: a cjd documentary
-
4:44
8-year-old girl battling a rare brain disease she calls ‘awesome’ | today
-
2:43
gabe's story: life with a rare genetic disorder
-
36:18
patient centric approaches for rare and ultra-rare diseases
-
4:35
episode 18 - the role of specialty pharmacies in rare diseases
-
1:30:02
surviving and thriving with knee arthritis | wednesday wellness
-
57:24
natural history studies for rare diseases
-
1:04:54
the rare disease drug dilemma: great value, high price, limited access?
-
36:53
'drug repurposing as a strategy for rare disease charities'- rick thompson
-
1:02:16
rare disease drug launch – lessons learned to ensure success is not a rare event
-
57:10
rare diseases are not rare – a training on rare disease resources
-
36:07
innovative solutions for fast tracking drugs for rare diseases
-
46:42
the scary future of rare disease management
-
0:11
rare disease #drugsafety #rarediseases
-
20:55
why rare disease research is so important
-
0:09
rare disease: could existing drugs turn the tide? #shorts
-
50:17
what everyone affected by a rare disease should know about the orphan drug act